comprehensive -WSS

comprehensive

author：entertainment 2025-10-03 00:07:23 - browse：117

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the 110 years since it was founded. But the booming success of its diabetes and obesity drug is unlike anything executives have seen before.

The company’s mid-year operating profit jumped from 37.5 billion Danish kroner in 2022 to 48.9 billion Danish kroner this year — “probably the strongest growth in the history of the company,” Chief Financial Officer Karsten Munk Knudsen said during an August earnings call. The 30% growth rate came from sales of semaglutide, which Novo Nordisk sells for diabetes under the name Ozempic and for obesity as Wegovy.

With its new blockbuster drug in hand, Novo Nordisk is valued higher than the entire economy of Denmark, where it’s based.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Celiac disease study examines precisely how gluten triggers injury

entertainment

WSS

FDA early review: GLP

Federal judge rules Oregon’s tough new gun law is constitutional

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Grail faces three suits alleging harassment, retaliation

Georgia court denies Trump's request to quash DA's 2020 election probe

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

focus

comprehensive

knowledge

Guidelines to prevent youth baseball injuries need more muscle

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Activists slam private health insurers over coverage restrictions

Why police arrested suspected Gilgo Beach killer away from his house

Hepatitis C has a cure — but many Americans still lack access to it

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Continuity nursing helped my family in our darkest PICU moments

Boston Scientific acquires urology company Axonics for $3.7 billion

Activists slam private health insurers over coverage restrictions

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Wikipedia

Celiac disease study examines precisely how gluten triggers injury

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Grail faces three suits alleging harassment, retaliation

Care demand spikes challenge UnitedHealth’s provider arm

Grail faces three suits alleging harassment, retaliation

Nonprofit, backed by Microsoft, to certify AI tools in health care

leisure time

entertainment

Wikipedia

entertainment